These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 23702179)
21. Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit. Tan DH; Walmsley SL Crit Care Clin; 2013 Jul; 29(3):603-20. PubMed ID: 23830655 [TBL] [Abstract][Full Text] [Related]
23. Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study. Janssen S; Osbak K; Holman R; Hermans S; Moekotte A; Knap M; Rossatanga E; Massinga-Loembe M; Alabi A; Adegnika A; Meenken C; van Vugt M; Kremsner PG; Meintjes G; van der Poll T; Grobusch MP Infection; 2017 Oct; 45(5):669-676. PubMed ID: 28349491 [TBL] [Abstract][Full Text] [Related]
24. HIV infection-related tuberculosis: clinical manifestations and treatment. Sterling TR; Pham PA; Chaisson RE Clin Infect Dis; 2010 May; 50 Suppl 3():S223-30. PubMed ID: 20397952 [TBL] [Abstract][Full Text] [Related]
25. Current issues in critical care of the human immunodeficiency virus-infected patient. Morris A; Masur H; Huang L Crit Care Med; 2006 Jan; 34(1):42-9. PubMed ID: 16374154 [TBL] [Abstract][Full Text] [Related]
26. [Tuberculosis and HIV co-infection: a therapeutic challenge]. Charbonnier F; Calmy A; Janssens JP Rev Med Suisse; 2011 Nov; 7(318):2295-6, 2298-300. PubMed ID: 22400365 [TBL] [Abstract][Full Text] [Related]
27. Immune reconstitution inflammatory syndrome in an HIV-infected patient with disseminated coccidioidomycosis. Lin AY; Chun V; Dhamija A; Bordin-Wosk T; Kadakia A Int J STD AIDS; 2019 Aug; 30(9):923-926. PubMed ID: 31159717 [No Abstract] [Full Text] [Related]
28. Acute appendicitis as a manifestation of the immune reconstitution inflammatory syndrome. Machala L; Jilich D; Rozsypal H; Holub M Curr HIV Res; 2009 Sep; 7(5):473-4. PubMed ID: 19925398 [TBL] [Abstract][Full Text] [Related]
29. Strongyloidiasis-Related IRIS. Bar-Yoseph H; Zohar Y; Lorber M J Int Assoc Provid AIDS Care; 2017; 16(1):8-10. PubMed ID: 27733639 [TBL] [Abstract][Full Text] [Related]
30. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Davies MA; Meintjes G Clin Infect Dis; 2009 Sep; 49(6):973-5. PubMed ID: 19673616 [No Abstract] [Full Text] [Related]
31. Critical Care in Human Immunodeficiency Virus-Infected Patients. Akgün KM; Miller RF Semin Respir Crit Care Med; 2016 Apr; 37(2):303-17. PubMed ID: 26974306 [TBL] [Abstract][Full Text] [Related]
32. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE; N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913 [TBL] [Abstract][Full Text] [Related]
33. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615 [TBL] [Abstract][Full Text] [Related]
35. Leprosy and HIV, where are we at? Lockwood DN; Lambert SM Lepr Rev; 2010 Sep; 81(3):169-75. PubMed ID: 21067057 [TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients. Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514 [TBL] [Abstract][Full Text] [Related]
37. [The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaría del Plan Nacional sobre el Sida) recommendations for the treatment of tuberculosis in HIV-infected individuals (Updated January 2013)]. Rivero A; Pulido F; Caylá J; Iribarren JA; Miró JM; Moreno S; Pérez-Camacho I; ; Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):672-84. PubMed ID: 23541879 [TBL] [Abstract][Full Text] [Related]
38. Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C. Braitstein P; Palepu A; Dieterich D; Benhamou Y; Montaner JS AIDS; 2004 Nov; 18(17):2221-34. PubMed ID: 15577534 [TBL] [Abstract][Full Text] [Related]
39. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections: Study protocol for antiretroviral therapy timing in AIDS patients with toxoplasma encephalitis. Zeng YM; Li Y; He XQ; Huang YQ; Liu M; Yuan J; Bai Y; Lu YQ; Li H; Chen YK Medicine (Baltimore); 2020 Jul; 99(29):e21141. PubMed ID: 32702867 [TBL] [Abstract][Full Text] [Related]